Khiron Life Sciences Corp.
KHRNF · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,451 | -$2,206 | -$5,418 | -$19,953 |
| Dep. & Amort. | $556 | $653 | $596 | $151 |
| Deferred Tax | $0 | $0 | $0 | $14,401 |
| Stock-Based Comp. | $0 | $338 | $309 | -$246 |
| Change in WC | -$2,026 | $1,002 | $351 | $193 |
| Other Non-Cash | -$450 | -$1,787 | $1,359 | $289 |
| Operating Cash Flow | -$5,043 | -$2,000 | -$2,803 | -$5,166 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$873 | -$465 | -$317 | -$1,130 |
| Net Acquisitions | $0 | -$8 | $8 | -$342 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $1 | -$1 | $8 | -$342 |
| Investing Cash Flow | -$872 | -$474 | -$309 | -$1,472 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $863 | -$253 | -$194 | $472 |
| Stock Issued | $0 | $3,863 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $3,862 | $0 | $5,458 |
| Financing Cash Flow | $864 | $3,609 | -$194 | $471 |
| Forex Effect | $1,172 | -$445 | -$490 | -$335 |
| Net Chg. in Cash | -$3,880 | $691 | -$3,796 | -$6,500 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,818 | $5,127 | $8,923 | $15,423 |
| End Cash | $1,938 | $5,818 | $5,127 | $8,923 |
| Free Cash Flow | -$5,916 | -$2,465 | -$3,120 | -$6,296 |